News Articles | Pfizer Singapore

Biopharma Leaders Unite To Stand With Science

Pfizer & BioNTech to Supply Singapore with Vaccine Candidate to Combat COVID-19

PFIZER INVESTS $120MIL IN BIOTECH INNOVATION

Pfizer Confirms U.S. Patent Term Extension for IBRANCE® (palbociclib) Until March 2027

AGREEMENT REACHED WITH COVAX FOR ADVANCE PURCHASE OF COVID-19 VACCINE

RECENT PRESS RELEASES

04/01/2021 - US FDA Accepts Regulatory Submission from Pfizer and OPKO for Review of Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency

29/12/2020 - Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®

28/12/2020 - LORBRENA® (lorlatinib) sNDA in Previously Untreated ALK-Positive Lung Cancer Accepted for Priority Review by U.S. FDA

28/12/2020 - Myovant Sciences and Pfizer Announce Collaboration to Develop and Commercialize Relugolix in Oncology and Women's Health

23/12/2020 - Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine

22/12/2020 - Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts

21/12/2020 - Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine

21/12/2020 - Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine

14/12/2020 - Pfizer and BioNTech to Supply Singapore with their BNT162b2 mRNA-based Vaccine Candidate to Combat COVID-19

14/12/2020 - Pfizer and BioNTech Provide Data from German Phase 1/2 Study Further Characterizing Immune Response Following Immunization with Lead COVID-19 Vaccine Candidate BNT162b2

12/12/2020 - U.S. CDC Committee of Independent Health Experts Recommends Vaccination with Pfizer and BioNTech COVID-19 Vaccine for Persons Ages 16 Years and Older

12/12/2020 - Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19

11/12/2020 - BAVENCIO® (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma

11/12/2020 - Pfizer Declares First-Quarter 2021 Dividend

10/12/2020 - Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S.